| |
| |
|
| Insider
Information: |
Moulder Leon O Jr |
| Relationship: |
|
| City: |
Bloomington |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
140,518 |
|
|
Indirect Shares
|
1,536,745 |
|
|
| Direct
Value |
$679,048 |
|
|
|
Indirect Value
|
$1,046,407 |
|
|
| Total
Shares |
1,677,263 |
|
|
| Total
Value |
$1,725,454 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MGI Pharma Inc |
MOGN |
President & CEO, Direc... |
2008-01-28 |
0 |
2008-01-23 |
0 |
Premium* |
|
|
New Abraxis Inc |
ABII |
President & CEO, Direc... |
2009-04-29 |
50,000 |
2009-04-29 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
Chief Executive Office... |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Trevena Inc |
TRVN |
Director |
2019-02-01 |
50,000 |
2019-02-01 |
100,000 |
Premium* |
|
|
Zai Lab Ltd |
ZLAB |
|
2023-06-29 |
40,518 |
2021-01-15 |
0 |
Premium* |
|
|
Dianthus Therapeutics Ord Shs |
DNTH |
|
|
0 |
2024-01-22 |
1,436,745 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSRO |
Tesaro, Inc. |
CHIEF EXECUTIVE OFFICEROfficer |
• • – |
2012-06-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
567,857 |
|
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Director |
– • – |
2023-09-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,270,078 |
|
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2004-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
62,000 |
|
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2005-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
199,000 |
|
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2006-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
221,889 |
|
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2007-06-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
209,273 |
0 |
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2008-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
48,500 |
0 |
- |
|
| ABII |
New Abraxis Inc |
President & CEO |
• • – |
2009-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Chief Executive Officer |
• • – |
2012-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
428,571 |
996,428 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Chief Executive Officer |
• • – |
2016-06-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
100 |
1,006,328 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Chief Executive Officer |
• • – |
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
1,018,828 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Chief Executive Officer |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,836 |
1,034,664 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,852 |
13,852 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,763 |
21,615 |
0 |
- |
|
| TRVN |
Trevena Inc |
Director |
– • – |
2019-02-01 |
4 |
B |
$1.02 |
$102,000 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2005-01-25 |
4 |
OE |
$3.55 |
$275,125 |
D/D |
70,000 |
194,000 |
|
- |
|
| TRVN |
Trevena Inc |
Director |
– • – |
2014-12-09 |
4 |
B |
$3.96 |
$119,592 |
D/D |
30,200 |
30,200 |
2.39 |
- |
|
| TRVN |
Trevena Inc |
Director |
– • – |
2014-12-10 |
4 |
B |
$4.06 |
$80,388 |
D/D |
19,800 |
50,000 |
2.39 |
- |
|
| TSRO |
Tesaro, Inc. |
Chief Executive Officer |
• • – |
2012-08-30 |
4 |
B |
$11.69 |
$116,900 |
D/D |
10,000 |
1,006,428 |
2.81 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
|
– • – |
2024-01-22 |
4 |
A |
$12.00 |
$2,000,004 |
I/I |
166,667 |
1,436,745 |
0 |
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2006-08-04 |
4 |
B |
$14.15 |
$28,313 |
D/D |
2,000 |
202,589 |
2.81 |
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2005-10-27 |
4 |
B |
$18.84 |
$37,689 |
D/D |
2,000 |
201,000 |
2.81 |
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2006-07-15 |
4 |
D |
$20.58 |
$8,458 |
D/D |
(411) |
200,589 |
|
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2007-05-10 |
4 |
D |
$21.14 |
$55,302 |
D/D |
(2,616) |
219,273 |
0 |
- |
|
| MOGN |
MGI Pharma Inc |
President & CEO |
• • – |
2007-08-31 |
4 |
D |
$23.57 |
$38,537 |
D/D |
(1,635) |
207,638 |
0 |
- |
|
33 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
